Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children. (abre una nueva ventana)

Ali S, Gassas A, Kirby-Allen M, Krueger J, Ali M, Schechter T

Fuente‎: Pediatr Transplant 2017;21(6):e13017.

Indexado en‎: PubMed 28653480

DOI‎: 10.1111/petr.13017

https://www.ncbi.nlm.nih.gov/pubmed/28653480 (abre una nueva ventana)

The role of interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with solid tumors, lymphoma, acute myeloid leukemia and bone marrow failure syndromes. (abre una nueva ventana)

Bhatia M, Davenport V, Cairo MS.

Fuente‎: Leuk Lymphoma 2007;48(1):9-15.

Indexado en‎: PubMed 17325843

DOI‎: 10.1080/10428190600909115

https://www.ncbi.nlm.nih.gov/pubmed/17325843 (abre una nueva ventana)

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial. (abre una nueva ventana)

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Fuente‎: Lancet 2003;361(9354):275-80.

Indexado en‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860 (abre una nueva ventana)

Romiplostim for immune thrombocytopenia in neuroblastoma patients receiving chemotherapy. (abre una nueva ventana)

Fassel H, Bussel JB, Roberts SS, Modak S

Fuente‎: J Pediatr Hematol Oncol 2019;41(4):e257-9.

Indexado en‎: PubMed 29683946

DOI‎: 10.1097/MPH.0000000000001187

https://www.ncbi.nlm.nih.gov/pubmed/29683946 (abre una nueva ventana)

Romiplostim for therapy-related thrombocytopenia in pediatric malignancies. (abre una nueva ventana)

Jacobson AE, Shah N, Setty BA

Fuente‎: Pediatr Blood Cancer 2017;64(8):e26473.

Indexado en‎: PubMed 28150377

DOI‎: 10.1002/pbc.26473

http://www.ncbi.nlm.nih.gov/pubmed/28150377 (abre una nueva ventana)

Eltrombopag for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation in children. (abre una nueva ventana)

Li S, Wu R, Wang B, Fu L, Zhu G, Zhou X, Ma J, Zhang L, Qin M

Fuente‎: J Pediatr Hematol Oncol 2019;41(1):38-41.

Indexado en‎: PubMed 30080752

DOI‎: 10.1097/MPH.0000000000001263

https://www.ncbi.nlm.nih.gov/pubmed/30080752 (abre una nueva ventana)

Romiplostim for secondary thrombocytopenia following allogeneic stem cell transplantation in children. (abre una nueva ventana)

Maximova N, Zanon D, Rovere F, Maestro A, Schillani G, Paparazzo R

Fuente‎: Int J Hematol 2015;102(5):626-32.

Indexado en‎: PubMed 26084627

DOI‎: 10.1007/s12185-015-1821-1

https://www.ncbi.nlm.nih.gov/pubmed/26084627 (abre una nueva ventana)

Recombinant human erythropoietin reduces the need for erythrocyte and platelet transfusions in pediatric patients with sarcoma: a randomized, double-blind, placebo-controlled trial. (abre una nueva ventana)

Porter JC, Leahey A, Polise K, Bunin G, Manno CS

Fuente‎: J Pediatr 1996;129(5):656-60.

Indexado en‎: PubMed 8917229

DOI‎: 10.1016/s0022-3476(96)70145-2

https://www.ncbi.nlm.nih.gov/pubmed/8917229 (abre una nueva ventana)

Chemotherapy induced thrombocytopenia in pediatric oncology. (abre una nueva ventana)

Tamamyan G, Danielyan S, Lambert MP

Fuente‎: Crit Rev Oncol Hematol 2016;99:299-307.

Indexado en‎: PubMed 26811139

DOI‎: 10.1016/j.critrevonc.2016.01.005

https://www.ncbi.nlm.nih.gov/pubmed/26811139 (abre una nueva ventana)

Oncological management of pediatric cancer patients belonging to Jehovahs Witnesses: a two-institutional experience report. (abre una nueva ventana)

Tenenbaum T, Hasan C, Kramm CM, Janssen G, Laws HJ, Wessalowski R, Bode U, Göbel U

Fuente‎: Onkologie 2004;27(2):131-7.

Indexado en‎: PubMed 15138344

DOI‎: 10.1159/000076901

https://www.ncbi.nlm.nih.gov/pubmed/15138344 (abre una nueva ventana)

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience. (abre una nueva ventana)

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Fuente‎: Ann Oncol 2005;16(1):139-45.

Indexado en‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951 (abre una nueva ventana)

Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. (abre una nueva ventana)

Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, Fackler-Schwalbe I, Fischer J, Gäckle R, Geer T, Harms P, Löffler B, Ohl S, Otremba B, Raab M, Schönrock-Nabulsi P, Strobel G, Winter R, Link H

Fuente‎: Blood 1998;91(10):3601-6.

Indexado en‎: PubMed 9572994

https://www.ncbi.nlm.nih.gov/pubmed/9572994 (abre una nueva ventana)